FOR RESEARCH PURPOSES ONLY — Not for human or veterinary use. Citations describe published research and do not establish this product’s identity, purity, safety, or effects.
Metabolic Peptide

GLP-3

  • Retatrutide
  • LY3437943
  • GIP/GLP-1/Glucagon Tri-Agonist

A 39-residue triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors — used as a research compound in metabolic and incretin-signaling studies.

GLP-3
$185.00$130.00/ 30mg vial
Strength
View CoA PDF

Published CoA PDFs · USA warehouse shipping

  • Published CoA PDFs
  • Free shipping on $300+
  • Shipment + damage protection
  • 256-bit SSL checkout
GLP-3$185.00$130.00

Triple receptor agonist

GIP, GLP-1, and glucagon receptor research.

39-residue design

Stabilized backbone characterized in published research literature.

Batch documentation

Review available batch-specific analytical records.

MOLECULAR PROFILE

What Is GLP-3?

GLP-3 is the storefront label for the listed retatrutide (LY3437943) research material. Retatrutide is a 39-residue peptide studied for agonism at GIP, GLP-1, and glucagon receptors. The cited trials evaluated investigational formulations and do not establish the identity, purity, or effects of this retail product.

GLP-3 is the Vorix catalog name for retatrutide research material. Choose the 10 mg or 30 mg vial before selecting your package; the product selector and CoA link follow the selected strength.

COMPOUND INFORMATION

Technical specifications

Type
Synthetic 39-residue triagonist peptide
Molecular weight
~4,900 g/mol
Appearance
White lyophilized powder
Analytical documentation
Refer to available batch-specific analytical records.
FAQ

GLP-3 — common research questions

Straight answers for researchers comparing purity, CoA documentation, kits, and shipping.

Is GLP-3 for research use only?

Yes. Vorix Labs materials are sold for laboratory / in-vitro research only, not for human or veterinary use or clinical applications.

Where can I find a CoA for GLP-3?

Use the product page’s View CoA PDF link or the CoA library to open the report hosted on this website. Check the sample, analysis date and actual measured results in the PDF. Contact us if you need to confirm which report applies to the stock you are ordering.

What package sizes are available for GLP-3?

The catalog lists 30 mg / 10 mg per vial. Select single vials or a kit of 10 in the product selector. A kit contains 10 vials of the selected product and strength; availability and the current total are shown before adding to cart.

Where do orders ship from?

Orders ship from our US warehouse. See the shipping page for processing times, available services and current charges; the checkout displays the applicable shipping options.

SOURCES & REFERENCES

Peer-reviewed research

  1. N Engl J Med
    Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
    2023· DOI: 10.1056/NEJMoa2301972· PMID: 37366315View on PubMed →
    Jastreboff AM, Kaplan LM, Frías JP et al.

    Clinical trial of investigational retatrutide; not the storefront product labeled GLP-3.

  2. Lancet
    Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
    2023· DOI: 10.1016/S0140-6736(23)01053-X· PMID: 37385280View on PubMed →
    Rosenstock J, Frias J, Jastreboff AM et al.

    Clinical trial of investigational retatrutide; does not establish identity, purity or effects of this retail material.

View all related research on PubMed
RELATED RESEARCH

Frequently researched together

IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.